← Top stories
IPO● Neutral for Indian equities
Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: Sources
The brief
- HRV Pharma is preparing for an IPO, with a draft prospectus likely in H1 2027
- CEO Hari Kiran Chereddi forecasts Rs 1,000 crore revenue
- Fortis says independent audit will establish non-involvement in Singh brothers’ share transfers
- Fortis confident of clean chit from audit in Singh brothers’ dispute
- Supreme Court allows independent forensic audit of Fortis transactions in Daiichi dispute
- Regulator mulls digital platform for drugmakers' test reports
- Mint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registry